Evidence map›Paper›PMID 32798922›Full record

Trial reportComputers in biology and medicine2020

Prediction of respiratory decompensation in Covid-19 patients using machine learning: The READY trial.

Hoyt Burdick, Carson Lam, Samson Mataraso, Anna Siefkas, Gregory Braden, R Phillip Dellinger, Andrea McCoy, Jean-Louis Vincent, Abigail Green-Saxena, Gina Barnes and 4 more

Abstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Computers in biology and medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Combining blood glucose and SpOScientific reports · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. A Review of the Machine Learning Algorithms for Covid-19 Case Analysis.IEEE transactions on artificial intelligence · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hoyt BurdickCabell Huntington Hospital, Huntington, WV, USA; Marshall University School of Medicine, Huntington, WV, USA.
Carson LamDascena, Inc., San Francisco, CA, USA.
Samson MatarasoDascena, Inc., San Francisco, CA, USA.
Anna SiefkasDascena, Inc., San Francisco, CA, USA. Electronic address: anna@dascena.com.
Gregory BradenKidney Care and Transplant Associates of New England, Springfield, MA, USA.
R Phillip DellingerDivision of Critical Care Medicine, Cooper University Hospital/Cooper Medical School of Rowan University, Camden, NJ, USA.
Andrea McCoyCape Regional Medical Center, Cape May Court House, NJ, USA.
Jean-Louis VincentDepartment of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Abigail Green-SaxenaDascena, Inc., San Francisco, CA, USA.
Gina BarnesDascena, Inc., San Francisco, CA, USA.
Jana HoffmanDascena, Inc., San Francisco, CA, USA.
Jacob CalvertDascena, Inc., San Francisco, CA, USA.
Emily PellegriniDascena, Inc., San Francisco, CA, USA.
Ritankar DasDascena, Inc., San Francisco, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCurrently, physicians are limited in their ability to provide an accurate prognosis for COVID-19 positive patients. Existing scoring systems have been ineffective for identifying patient decompensation. Machine learning (ML) may offer an alternative strategy. A prospectively validated method to predict the need for ventilation in COVID-19 patients is essential to help triage patients, allocate resources, and prevent emergency intubations and their associated risks.

methodsIn a multicenter clinical trial, we evaluated the performance of a machine learning algorithm for prediction of invasive mechanical ventilation of COVID-19 patients within 24 h of an initial encounter. We enrolled patients with a COVID-19 diagnosis who were admitted to five United States health systems between March 24 and May 4, 2020.

results197 patients were enrolled in the REspirAtory Decompensation and model for the triage of covid-19 patients: a prospective studY (READY) clinical trial. The algorithm had a higher diagnostic odds ratio (DOR, 12.58) for predicting ventilation than a comparator early warning system, the Modified Early Warning Score (MEWS). The algorithm also achieved significantly higher sensitivity (0.90) than MEWS, which achieved a sensitivity of 0.78, while maintaining a higher specificity (p < 0.05).

conclusionsIn the first clinical trial of a machine learning algorithm for ventilation needs among COVID-19 patients, the algorithm demonstrated accurate prediction of the need for mechanical ventilation within 24 h. This algorithm may help care teams effectively triage patients and allocate resources. Further, the algorithm is capable of accurately identifying 16% more patients than a widely used scoring system while minimizing false positive results.

Indexed as

BetacoronavirusMachine LearningAdultAgedAged, 80 and overAlgorithmsClinical Laboratory TechniquesComputational BiologyCoronavirus InfectionsCOVID-19COVID-19 Drug TreatmentCOVID-19 TestingFemaleHumansMaleMiddle AgedCOVID-19Machine learningMechanical ventilationPrediction

Identifiers

PMID32798922
PMCPMC7410013

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.